construction release_alert

Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.

cancel

Outcomes Database to prospectivelY aSSEss changing therapY landscape in Renal Cell Carcinoma (ODYSSEY RCC)

Clinical Trial Grant

Duke Scholars

Principal Investigator Daniel James George Medicine, Medical Oncology

Administered By

Duke Clinical Research Institute

Awarded By

Pfizer, Inc.

Start Date

December 29, 2020

End Date

December 31, 2025

Administered By

Duke Clinical Research Institute

Awarded By

Pfizer, Inc.

Start Date

December 29, 2020

End Date

December 31, 2025